CXCR2 antagonist 2
|
C647636-1mg
|
≥99% |
2647464-91-1 |
1mg
|
¥ 1700.9
|
期货,请咨询 |
阿拉丁 |
CXCR2 antagonist 2
|
C647636-10mg
|
≥99% |
2647464-91-1 |
10mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
Ceramides Mixture
|
C647629-50mg
|
≥98% |
100403-19-8 |
50mg
|
¥ 3300.9
|
期货,请咨询 |
阿拉丁 |
Ceramides Mixture
|
C647629-25mg
|
≥98% |
100403-19-8 |
25mg
|
¥ 2200.9
|
期货,请咨询 |
阿拉丁 |
Ceramides Mixture
|
C647629-100mg
|
≥98% |
100403-19-8 |
100mg
|
¥ 4950.9
|
期货,请咨询 |
阿拉丁 |
β-Cyclogeraniol
|
C647627-25mg
|
≥98% |
472-20-8 |
25mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
β-Cyclogeraniol
|
C647627-10mg
|
≥98% |
472-20-8 |
10mg
|
¥ 800.9
|
期货,请咨询 |
阿拉丁 |
Clindamycin-13C,d3
|
C647617-1mg
|
|
2140264-63-5 |
1mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
CD73-IN-4
|
C647604-5mg
|
≥99% |
2216764-29-1 |
5mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |
CD73-IN-4
|
C647604-50mg
|
≥99% |
2216764-29-1 |
50mg
|
¥ 22000.9
|
期货,请咨询 |
阿拉丁 |
CD73-IN-4
|
C647604-25mg
|
≥99% |
2216764-29-1 |
25mg
|
¥ 13500.9
|
期货,请咨询 |
阿拉丁 |
CD73-IN-4
|
C647604-10mg
|
≥99% |
2216764-29-1 |
10mg
|
¥ 6800.9
|
期货,请咨询 |
阿拉丁 |
CD73-IN-4
|
C647604-100mg
|
≥99% |
2216764-29-1 |
100mg
|
¥ 34000.9
|
期货,请咨询 |
阿拉丁 |
Clitocine
|
C647589-5mg
|
≥95% |
105798-74-1 |
5mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |
Clitocine
|
C647589-50mg
|
≥95% |
105798-74-1 |
50mg
|
¥ 19000.9
|
期货,请咨询 |
阿拉丁 |
Clitocine
|
C647589-10mg
|
≥95% |
105798-74-1 |
10mg
|
¥ 6800.9
|
期货,请咨询 |
阿拉丁 |
Clitocine
|
C647589-100mg
|
≥95% |
105798-74-1 |
100mg
|
¥ 29000.9
|
期货,请咨询 |
阿拉丁 |
CM03
|
C647588-5mg
|
≥98% |
2101208-44-8 |
5mg
|
¥ 3000.9
|
期货,请咨询 |
阿拉丁 |
CM03
|
C647588-50mg
|
≥98% |
2101208-44-8 |
50mg
|
¥ 14500.9
|
期货,请咨询 |
阿拉丁 |
CM03
|
C647588-25mg
|
≥98% |
2101208-44-8 |
25mg
|
¥ 9500.9
|
期货,请咨询 |
阿拉丁 |
CM03
|
C647588-10mg
|
≥98% |
2101208-44-8 |
10mg
|
¥ 4800.9
|
期货,请咨询 |
阿拉丁 |
Cleistanthin B
|
C647578-1mg
|
≥99% |
30021-77-3 |
1mg
|
¥ 6400.9
|
期货,请咨询 |
阿拉丁 |
Carcinoembryonic Antigen (CEA)
|
C647562-5mg
|
≥99% |
168635-85-6 |
5mg
|
¥ 4699.9
|
现货 |
阿拉丁 |
Carcinoembryonic Antigen (CEA)
|
C647562-1mg
|
≥99% |
168635-85-6 |
1mg
|
¥ 1339.9
|
现货 |
阿拉丁 |